Product Details

Mar-Azithromycin

Azithromycin
250 mg
Tablet


DIN/PIN/NPN

02452324

Manufacturer

Marcan Pharmaceuticals Inc.

Formulary Listing Date

2016-11-30  

Unit Price

0.9410

Amount MOH Pays

0.9410

Coverage Status

General Benefit

ODB Formulary Therapeutic Classification

Therapeutic Note

Antibiotics, Erythromycins (8:12:12): Erythromycin alone is not adequate for the treatment of H. influenzae infections. It lacks consistently reliable activity against this organism. Erythromycin is a potent inhibitor of hepatic oxidation of some drugs and may cause significant elevation of blood levels of astemizole, carbamazepine, cyclosporine, digoxin, dihydropyridines, terfenadine, theophylline and warfarin. Potentially fatal arrhythmias (torsade de pointes) can occur with the combination of erythromycin and astemizole or terfenadine.

ATC Code

J01FA10

Interchangeable Products

DIN/ PIN/ NPN Brand name Unit Price Amount MOH pays
02212021 Zithromax 5.4382 0.9410
02265826 Sandoz Azithromycin 0.9410 0.9410
02275309 Riva-Azithromycin 0.9410 0.9410
02261634 PMS-Azithromycin 0.9410 0.9410
02479680 NRA-Azithromycin 0.9410 0.9410
02267845 Novo-Azithromycin 0.9410 0.9410
02502038 M-Azithromycin 0.9410 0.9410
02452324 Mar-Azithromycin 0.9410 0.9410
02452308 Jamp-Azithromycin 0.9410 0.9410
02442434 Azithromycin 0.9410 0.9410
02330881 Azithromycin 0.9410 0.9410
02415542 Apo-Azithromycin Z 0.9410 0.9410
02247423 Apo-Azithromycin 0.9410 0.9410
02480700 AG-Azithromycin 0.9410 0.9410
 

LU Clinical Criteria

NO  

EAP Criteria

NO

Product Monograph

View Monograph